|
|
||||||||
Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas and Department of Internal Medicine and Radiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75231
| |
ABSTRACT |
|---|
|
|
|---|
Cardiac muscle adapts well to changes in loading conditions. For example, left ventricular (LV) hypertrophy may be induced physiologically (via exercise training) or pathologically (via hypertension or valvular heart disease). If hypertension is treated, LV hypertrophy regresses, suggesting a sensitivity to LV work. However, whether physical inactivity in nonathletic populations causes adaptive changes in LV mass or even frank atrophy is not clear. We exposed previously sedentary men to 6 (n = 5) and 12 (n = 3) wk of horizontal bed rest. LV and right ventricular (RV) mass and end-diastolic volume were measured using cine magnetic resonance imaging (MRI) at 2, 6, and 12 wk of bed rest; five healthy men were also studied before and after at least 6 wk of routine daily activities as controls. In addition, four astronauts were exposed to the complete elimination of hydrostatic gradients during a spaceflight of 10 days. During bed rest, LV mass decreased by 8.0 ± 2.2% (P = 0.005) after 6 wk with an additional atrophy of 7.6 ± 2.3% in the subjects who remained in bed for 12 wk; there was no change in LV mass for the control subjects (153.0 ± 12.2 vs. 153.4 ± 12.1 g, P = 0.81). Mean wall thickness decreased (4 ± 2.5%, P = 0.01) after 6 wk of bed rest associated with the decrease in LV mass, suggesting a physiological remodeling with respect to altered load. LV end-diastolic volume decreased by 14 ± 1.7% (P = 0.002) after 2 wk of bed rest and changed minimally thereafter. After 6 wk of bed rest, RV free wall mass decreased by 10 ± 2.7% (P = 0.06) and RV end-diastolic volume by 16 ± 7.9% (P = 0.06). After spaceflight, LV mass decreased by 12 ± 6.9% (P = 0.07). In conclusion, cardiac atrophy occurs during prolonged (6 wk) horizontal bed rest and may also occur after short-term spaceflight. We suggest that cardiac atrophy is due to a physiological adaptation to reduced myocardial load and work in real or simulated microgravity and demonstrates the plasticity of cardiac muscle under different loading conditions.
magnetic resonance imaging; left ventricular mass; left ventricular end-diastolic volume; right ventricular mass; right ventricular end-diastolic volume
| |
INTRODUCTION |
|---|
|
|
|---|
CARDIAC MUSCLE IS WELL REGULATED in response to changes in loading conditions (9, 32, 34, 54). An increase in cardiac muscle mass is the basic adaptive response to increased volume or pressure loading, which can be seen as specific molecular changes in contractile proteins (8, 30). The signaling processes that regulate myocardial mass have been studied intensively over the past few years, and many pathways involving hemodynamic, neurohumoral, and pathological stimuli that lead to myocardial hypertrophy have been identified (9, 14, 52, 62). Conversely, the mechanisms and pathways leading to the opposite response, i.e., cardiac atrophy, are less clear, in part because of the limited availability of physiologically relevant animal models (33, 34). For whole animals (including humans), chronic volume loading of the left ventricle is associated with eccentric hypertrophy (increased mass and volume, with preserved mass/volume ratio) and increased chamber distensibility, whereas volume unloading is associated with eccentric atrophy and decreased chamber distensibility (10, 61).
In the absence of manifest cardiovascular disease, one model of chronic circulatory unloading in humans is sustained exposure to microgravity, either directly (i.e., spaceflight) or as simulated by bed rest. Both horizontal or head-down-tilt bed rest can be used as an analog for the adaptive responses of real microgravity, leading initially to a central fluid shift, with activation of volume regulatory mechanisms, loss of plasma volume, and restoration of a new hemodynamic steady state about halfway between the upright and supine positions (17, 35, 36). Thus both spaceflight and head-down-tilt bed rest result in decreased relative (to the supine position) volume loading of the heart and may lead to cardiac atrophy (17, 25, 35, 36). Studies in rodents after short-term spaceflight have shown evidence of decreased cardiac myocyte size, which is consistent with cardiac atrophy (23). A recent study in our laboratory has shown a decrease in the equilibrium volume of the left ventricle (volume at pressure = 0 mmHg) and a trend for left ventricular (LV) mass to decrease during head-down-tilt bed rest for 18 days, suggesting cardiac remodeling during bed rest (36). However, the limited precision of the methods used to measure LV mass in that study (echocardiography) reduced the ability to demonstrate cardiac atrophy with confidence over this short time period. Moreover, there are no reports available regarding the changes in right ventricular (RV) mass and volumes after physical deconditioning such as bed rest.
To determine whether cardiac atrophy occurs in humans during exposure to real or simulated microgravity, we exposed sedentary (physically inactive) men to prolonged supine bed rest and short-term spaceflight. To obtain the most precise and accurate data regarding changes in cardiac structure, magnetic resonance imaging (MRI) was used to measure both LV and RV mass and end-diastolic volume after bed rest and LV mass after spaceflight. We hypothesized that the heart is extremely plastic in response to physiological loading conditions and would exhibit significant changes in ventricular mass with cardiovascular "deconditioning" induced by bed rest and/or spaceflight.
| |
METHODS |
|---|
|
|
|---|
Subjects
Five healthy men with a mean age of 31 ± 5 yr volunteered to participate in the bed rest study. All five subjects completed 6 wk of strict supine bed rest and three out of five completed the total of 12 wk of bed rest. LV mass data were also obtained from four male astronauts (40 ± 2 yr) who participated the second German Spacelab Mission (D-2) with a duration of 10 days. Five additional control subjects matched for age with the bed rest subjects were also studied at baseline and then after at least 6 wk of uncontrolled, routine daily activity. All the subjects were healthy and none had any chronic medical problems as determined by a medical history, physical examination, electrocardiogram (ECG), and echocardiogram. All the bed rest subjects signed an informed consent form approved by the Institutional Review Boards of the University of Texas Southwestern Medical Center, Dallas, TX. In addition, all astronauts signed a consent form, approved by the Human Research Policy and Procedures Committee at the Johnson Space Center (Houston, TX), and the D-2 protocols were also approved by the review committee at the German Aerospace Research Establishment (Köln, Germany).Experimental Designs
Bed rest study. The bed rest subjects were in complete supine bed rest for 6 wk (n = 5), and three out of five finished a total of 12 wk. These subjects are a subset of subjects who were enrolled in a study of the mineral metabolic effects of prolonged bed rest reported previously (60). Subjects were kept at strict bed rest and were not allowed to elevate their heads more than 30° above the horizontal level. Horizontal movement was allowed, bedpan or urinal was used, and daily sponge baths were taken. The subjects had full 7-day metabolic evaluations during a 1-wk ambulatory control period before the beginning of bed rest and during the last week of bed rest. The mean daily caloric value of the metabolic diet was 2,206 Kcal with 74 g of protein, 83 g of fat, and 291 g of carbohydrate. This metabolic diet was repeated for the last 4 days of each bed rest week. Otherwise the subjects had a standard diet. Subjects were housed in the General Clinical Research Center at the University of Texas Southwestern Medical Center. Control subjects were freely ambulatory and pursued their usual occupational and recreational activities between the two MRI measurements.
Spaceflight study. The four astronauts studied included the payload crew for the D-2 mission (STS-55), which flew in space for 10 days in April 1993. This flight was a dedicated life-sciences mission and included 19 experiments from an international group of investigators with an emphasis on the cardiovascular, cardiopulmonary, and endocrine/metabolic effects of spaceflight. Submaximal exercise was performed by two subjects for brief periods (~10 min) on flight days 1, 3, and 7 as part of other investigations, but because of time constraints, no routine "maintenance" exercise was performed by this crew.
Study Protocols
The measurements in the bed rest study were done in the supine position pre-bed rest and were repeated after 2, 6, and 12 wk of bed rest. Hemodynamic data were obtained after at least 30 min of quiet rest in the laboratory and were repeated every 5 min until consecutive measurements of cardiac output (
c) were obtained that were
within 500 ml of each other (usually 20-30 min). The results of
these last two measurements were then averaged for each session. The
MRI data from astronauts were obtained 5 mo before the spaceflight and
within 12 h of landing after the 10-day Spacelab mission. The
hemodynamic data for the astronauts were obtained in conjunction with
an experiment examining the renal/neurohumoral responses to saline
infusion and the experimental details regarding the preflight and
in-flight data collection have been reported previously
(42). In this study, hemodynamic data were obtained at 6 and 9 mo before spaceflight in the supine position and in-flight on
mission day 5. During flight, the Spacelab was maintained at
sea-level atmospheric pressure and gas composition. The crew members
were asked not to alter their preflight exercise habits as reported
previously (6).
MRI Measurements
Bed rest. For the bed rest studies, MRI was performed on a 1.5-T Philips NT MRI scanner (Best, The Netherlands) at the Mary Nell and Ralph B. Rogers Magnetic Resonance Center at the University of Texas Southwestern Medical Center at Dallas, TX. The subject was positioned supine on the MRI table, and ECG monitoring leads were placed on the chest. Short-axis, gradient-echo, cine MRI sequences with a temporal resolution of 39 ms were obtained to calculate LV volumes as previously described (28). The heart was sectioned in 8-mm slices with 2 mm of gap spanning apex to base. Images were obtained with a 256 × 152 matrix and a 350 × 350-mm field of view. The repetition time was 14 ms, echo time was 8.1 ms, 2 phase encodes were acquired per cycle and the flip angle was 40.
LV mass was computed as the difference between epicardial and endocardial areas multiplied by the density of heart muscle, 1.05 g/ml (31). Previous studies in our laboratory and others have demonstrated that MRI with Simpson's rule technique results in highly accurate and reproducible measurements of LV mass (21, 31). In our hands, a regression equation of true LV mass = 7.14 + 0.91 × MRI mass estimate (in grams) has been reported, with a correlation coefficient between MRI and direct measurements of cadaver hearts of 0.99 and a standard error of estimate (SEE) of 6.8 g with intraobserver variability of 0.96, SEE 11.1 g (31). With the use of 10 short-axis slices through the heart at end diastole in the present study, the intraobserver variability for LV mass was 0.98, SEE 3.8 g, and for RV mass r = 0.97, SEE 2.1 g. For LV volume determination, the endocardial border of each slice was identified manually at end diastole and end systole, and volumes were calculated by summation (47). End diastole was defined as the first frame in each sequence and end systole as the frame with smallest endocardial area. LV volumes were calculated by using Simpson's rule technique as previously described (47). Mean wall thickness (MWT) for the entire left ventricle included the papillary muscle and was calculated as follows. For each short-axis slice, the epicardial area (LV chamber plus myocardial wall) and endocardial area (chamber area) were determined by using software on the imaging device. The "average" radius for each area was calculated by approximating the cross section as a circle and using the equation for the area of a circle (Area =
r2 or r = 
|
Spaceflight. A mobile 1.0-T magnet system manufactured by Picker International Medical Systems (now Marconi Medical, Cleveland, OH) was used for cardiac MRI studies before and after spaceflight. Breath hold, cardiac-gated long- and short-axis views of the heart were obtained by using a flow-compensated, gradient-echo (repetition time, 20 ms/echo time, 9 ms) segmented k-space or phase-encoding group technique. Specific parameters included 10-mm slices, a 38-cm field of view, a 192 × 256 matrix, undersampling with a total of 120 views, and a phase-encoding group of 5. This permitted cine imaging of a slice during a breath-hold of 24 cardiac cycles. Short-axis cine images were obtained at 10-12 levels to span the entire left ventricle. Images were then transferred to a workstation for analysis, which was performed by using the same techniques as for the bed rest study and therefore with the same accuracy and precision.
Heart Rate and Blood Pressure Measurements
Heart rate was monitored using the ECG (Hewlett-Packard). Blood pressure was measured in the arm by electrosphygmomanometry (Suntech 4240) with a microphone placed over the brachial artery and detection of the Korotkoff sounds gated to the ECG.Stroke Volume
In the bed rest study,
c was measured with a modification
of the acetylene-rebreathing technique using acetylene as the soluble
gas and helium as the insoluble gas (36, 55). With this
technique, pulmonary blood flow is calculated from the disappearance rate of acetylene in expired air, measured with a mass spectrometer (Marquette), after adequate mixing in the lung has been confirmed by a
stable helium concentration. This method has been validated in our
laboratory against standard invasive techniques, including thermodilution and direct Fick, over a range of
c from 2.75 to
27.00 l/min, with an r2 of 0.91 and an SEE of
1.1 l/min (44). For the D-2 mission, the same
acetylene-rebreathing method was used, except that argon was used
instead of helium as the inert gas (58). Stroke volume (SV) was calculated from
c, and heart rate was measured during rebreathing.
Statistics
Data are expressed as means ± SE. Statistical probability was assessed with one- or two-way repeated-measures ANOVA as appropriate, and the differences in means were evaluated by using the Student's paired t-test to test the difference between the values before and after each experiment. Actual P values are given in the text.| |
RESULTS |
|---|
|
|
|---|
Hemodynamic Data
c and SV decreased (P = 0.0009 and
P = 0.02, respectively) during the first 2 wk of bed
rest (Table 1). Otherwise, horizontal bed
rest did not cause significant changes in other hemodynamic variables.
Both
c and SV were also decreased (P = 0.004 and P = 0.00001, respectively) in-flight compared with
preflight supine
c and SV (Table 1).
|
LV Mass, MWT, and LV End-Diastolic Volume
LV mass decreased by 6 wk of bed rest by 8.0 ± 2.2% (P = 0.005, Fig. 1), and the three subjects who continued bed rest through 12 wk had an additional atrophy of 7.6 ± 2.3% (Fig. 2). In contrast, there was no change in LV mass for the control subjects (153.0 ± 12.2 vs. 153.4 ± 12.1 g, P = 0.81 for paired t-test; P = 0.012 for interaction statistic of two-way ANOVA comparing bed rest subjects with controls), and no individual subject had more than a 4.5-g (range 0.0-4.4 g) difference from one measurement to the other. Moreover, MWT decreased by 4 ± 2.5% (P = 0.01) after 6 wk of bed rest (Fig. 4). Similar to long-term bed rest, spaceflight for 10 days led to a trend toward decreased LV mass (12 ± 6.9%, P = 0.07) when compared with the preflight data (Fig. 3).
|
|
|
In contrast to LV mass, LV end-diastolic volume decreased (14 ± 1.7%, P = 0.002) when first measured at 2 wk of bed
rest (Fig. 4). For the entire group,
there was no further decrease in LV volume between 2 and 6 wk. In the
subgroup who remained in bed for 12 wk, LV end-diastolic volume
decreased an additional 8 ± 4.2% by 12 wk of bed rest (Fig. 2).
The LV mass-LV end-diastolic volume ratio (2.09 ± 0.16 and
2.00 ± 0.11) was increased after 2 and 6 wk, respectively,
compared with baseline (1.82 ± 0.11, P = 0.02).
|
RV Mass and RV End-Diastolic Volume
RV mass was decreased by 10 ± 2.7% (P = 0.06) after 6 wk of bed rest (Fig. 5). There was a tendency to decreased RV end-diastolic volume after 2 wk of bed rest, but the decrease (16 ± 8%, P = 0.06) was more prominent after 6 wk of bed rest.
|
| |
DISCUSSION |
|---|
|
|
|---|
The principal new finding of this study is that the human heart atrophies after bed rest and may also atrophy after spaceflight, presumably in response to decreased physiological loading. Specifically, we have shown that LV mass measured by MRI decreased clearly during prolonged strict supine bed rest in previously sedentary nonathletic men without cardiovascular disease, and a similar trend was observed after short-duration spaceflight. The decrease in LV mass noted first at 6 wk was associated with an earlier (2 wk) decrease in LV end-diastolic volume during bed rest, so that the LV mass-volume ratio increased acutely, resulting in a decrease in wall stress (i.e., load). In fact, the primary initial morphologic adaptation during bed rest was a decrease in LV end-diastolic volume that was most prominent when measured at 2 wk, secondary to the well-described loss of plasma volume during bed rest and spaceflight (17, 35). Thus bed rest deconditioning led to a remodeling (i.e., changes in cardiac morphology) of the heart first by changes in volume and secondarily via changes in muscle mass.
The changes in cardiac structure during short- and long-term bed rest have been under investigation for several years. Our present findings support earlier radiographic data that showed that the overall heart size (including both volume and mass) decreased after 3 wk of horizontal bed rest (50). Moreover, our previous studies in sedentary subjects undergoing head-down-tilt bed rest deconditioning for 18 days had significantly decreased resting supine LV end-diastolic volume and tended to have a decrease (5%) in LV mass after bed rest on the basis of measurements made by echocardiography. However, MRI provides better measurement precision than echocardiography (21, 31) and thus may be more sensitive for describing the morphological changes after bed rest or spaceflight. For example, it has been well documented that MRI has superior intraobserver variability compared with echocardiography for the purpose of measuring LV mass: intraobserver variability for MRI was 0.96, SEE 11.2 g, whereas for echocardiography r = 0.89, SEE 22.7 g (21). More recently, it has been demonstrated that the precision of LV mass measured with MRI (11 ± 8 g) is more than twice that observed with echocardiography (26 ± 49 g) (3). In addition, because MRI does not rely on geometric assumptions for the assessment of mass and volume, only MRI can be used accurately to study changes in the right ventricle after bed rest deconditioning. For these reasons, MRI is now widely considered to be the gold standard for the assessment of cardiac mass (11).
In comparison with bed rest, we detected a decrease in LV mass when using MRI in three out of four astronauts after spaceflight for only 10 days. Earlier radiographic data has shown that heart size decreases during short-term space missions similar to that observed after bed rest (25). However, the radiographic studies are not able to determine whether the changes in heart size reflect a change in heart volume or mass. Echocardiographic studies (M-mode) suggested an 8% decrease in LV mass in three Skylab 4 astronauts during an 84-day space mission, raising the possibility that cardiac atrophy might occur with spaceflight (25). The present study extends these previous observations by demonstrating additional, supportive evidence of cardiac atrophy in three out of four astronauts after even short duration spaceflight, which in some cases may be profound.
The hemodynamic alterations in humans during bed rest or spaceflight
are likely to play an important role in mediating the adaptation of
myocardial mass. The acute hemodynamic response to head-down bed rest
has been well described. With assumption of the head-down-tilt
position, there is a cephalad fluid shift, resulting in significant
increases in central venous pressure (CVP), LV dimensions, SV, and
c (19, 41). Within 24 h, there is a salt and
water diuresis, with a reduction in CVP and SV below supine values. In
one study, after 20 h of head-down-tilt bed rest, both SV and CVP
were lower, and heart rate was higher during lower body negative
pressure or upright tilt after compared with before bed rest,
to a magnitude similar to that observed after more prolonged periods of
bed rest (19). Although these subjects were not followed
for longer periods, the authors suggested that the adaptation was
essentially complete by the end of 24 h of head-down tilt.
A recent study carried out noninvasive hemodynamic measurements past
24 h, for the duration of 2 wk of
6° head-down-tilt bed rest
(36). SV essentially doubled with the transition from standing to the supine position, with an additional 15% increase during acute head-down tilt that peaked after 30 min (36).
Over the next 24 h, SV gradually decreased to below supine values, reaching a nadir at 48 h, with no further reduction over the next 2 wk. Heart rate and total peripheral resistance followed similar trends (36). These data confirm convincingly the
hypothesis that the acute response to head-down-tilt bed rest involves
removal of hydrostatic gradients, a central fluid shift, a transient
increase in transmural cardiac filling pressure and SV, and then a
rapid adaptation with loss of plasma volume that is mostly complete within 48 h of head-down tilt and does not progress over 2 wk, ultimately leading to a smaller heart with lower filling pressure and
therefore reduced preload and myocardial work (17, 24, 25, 35,
36, 41).
In the present study, the short-term cardiac adaptation to supine bed
rest was similar to these previous studies. Thus, when assessed after 2 wk, the LV end-diastolic volume measured by MRI, and SV measured by
acetylene rebreathing was significantly decreased, although LV mass was
minimally changed. As a consequence, the LV mass-volume ratio increased
substantially, resulting in a marked attenuation of wall stress via
Laplace's law (
= Pa/2h; where
= average circumferential wall stress, a = radius at
the endocardial surface, P = intraventricular pressure, and
h = wall thickness). In fact, we speculate that it is
this change in wall stress that may well be one of the key stimuli to
modify cardiac muscle mass during microgravity, as has been observed in
pathological conditions such as hypertension and valvular heart disease
(12). The fact that the LV mass-volume ratio remained
elevated compared with baseline after 6 wk of bed rest may be one
explanation for the continued atrophy in the three subjects who
remained at bed rest for 12 wk.
In this regard, it also is important to emphasize that one of the unique aspects of bed rest is the absence of the normal night time "volume load" associated with the change from upright to the supine position. We speculate that the loading of the heart and increase in wall stress during the night may produce a stimulus similar to that of endurance exercise (39) and under normal circumstances may be at least partly responsible for the maintenance of cardiac mass and volume. Thus, although the heart volume during bed rest ultimately adapts to a level greater than upright but less than supine, it may be the absence of this peak volume load at night that plays a major role in regulating the mass and wall thickness required to normalize wall stress.
In contrast to bed rest, with acute spaceflight exposure, CVP referenced to atmospheric pressure decreases to near 0 mmHg (5, 16). Simultaneously, however, LV end-diastolic volume and SV increase, suggesting an increase in cardiac filling. This apparent paradox may be explained by a larger reduction in pericardial pressure than in CVP, presumably due to removal of restraining forces from the chest wall, such that transmural cardiac filling pressure actually increases similar to ground-based simulations (5, 59). Recent data from transient periods of microgravity during parabolic flight have confirmed this hypothesis (57), suggesting that the effects of spaceflight or bed rest on acute transmural cardiac filling pressure and volume, the primary determinants of diastolic wall stress, are similar.
Despite this apparent similarity in steady-state hemodynamics, the
present study raises the possibility that there might be a more
prominent reduction in ventricular mass after short-term spaceflight
than after bed rest of the same duration. Thus we were unable to
demonstrate a reduction in LV or RV mass after 2 wk of supine bed rest,
despite a clear decrease in LV end-diastolic volume and a trend to
decreased RV end-diastolic volume. Of interest, Russian investigators
have suggested that adding
6° of head-down tilt is a better model
of actual weightlessness than supine bed rest, and this approach has
become the standard for microgravity simulation on earth
(17). In this regard, we have observed no change in LV and
RV mass after 2 wk of supine bed rest, a 5% decrease in LV mass after
2 wk of head-down-tilt bed rest, and a 12% decrease after 2 wk of
spaceflight, though it is important to note that none of these changes
was consistent enough to meet conventional criteria for statistical
significance given the small numbers of subjects studied. One
possibility for this difference may be that the astronauts were fitter
than the bed rest subjects and their results reflected the combination
of detraining as well as microgravity exposure. However, although we
did not have the opportunity to measure maximal oxygen uptake in the
bed rest subjects, it was only 37 ± 7 ml · kg
1 · min
1 (range
25-43 ml · kg
1 · min
1)
in the astronauts, making this possibility unlikely. We speculate that
the differences in hemodynamic loading, particularly the removal of
chest wall and pericardial constraint with spaceflight (5, 57,
59) may be responsible for differences in the rate of atrophy
among these three conditions. However, larger numbers of subjects must
be studied before such a speculation could be confirmed. Nevertheless,
this study confirms conclusively that at least by 6 wk of strict,
supine bed rest, the human heart does atrophy with a reduction in
volume and mass of the left ventricle and similar trends for the right ventricle.
However, despite the reduction in volume loading of the heart after adaptation to microgravity compared with the supine position, it is important to note that the human heart remains well loaded during bed rest with a SV (and presumably LV end-diastolic volume) greater than during upright quiet standing, as well as normal arterial pressure. Thus the human heart during bed rest or spaceflight is clearly different from animal models examining a completely unloaded circulation, such as heterotopic heart transplantation to the ear or abdomen (20, 22, 33, 34). Therefore it is possible that factors other than preload may play a role in mediating the changes in ventricular mass during bed rest.
In addition to changes in volume loading conditions, both bed rest and spaceflight induce confinement, which reduces physical activity compared with more freely ambulatory periods. In the present study, physical activity was severely restricted during bed rest. For the astronauts, this level of activity control was not possible. However, they were asked not to alter their preflight exercise habits during spaceflight and did not have any programmed physical exercise during this mission. Preliminary data from our laboratory have shown that the heart is extremely plastic in relation to changes in physical activity (37), so that during long-term endurance training a clear hypertrophy of the heart is observed whereas during bed rest of 6 wk the heart atrophies as shown in the present study. This range of adaptability with changes in physical activity may approach a full third of the cardiac mass when long-term bed rest is compared with long-term endurance training (37).
This plasticity of cardiac muscle during training and detraining also is well known in trained athletes. For example, cessation of intensive endurance training leads to a rapid (as quickly as 1 wk in studies in which early measurements were performed) atrophy of 10-22% in the exercise-induced hypertrophied heart seen as decreased LV wall thickness and LV mass measured by echocardiography (13, 15, 38). A decrease in presumed physiological hypertrophy was also detected in nonathletes 6 wk after cessation of a 6-wk exercise program (51). In addition, patients with high spinal cord lesions have a cardiac mass reduced by 25-35% compared with able-bodied nonathletic controls, which is reversible with electrically stimulated exercise training (40). The magnitude of this atrophy may represent a lower limit to the reduction in cardiac mass that can occur with cessation of all physical activity over a very prolonged period of time (years).
Animal studies designed to examine the mechanism of cardiac atrophy are consistent with the human data and indicate that regression of exercise-induced cardiac hypertrophy occurs rapidly (within 1-2 wk) after cessation of swimming training seen as decreases in LV mass by 15-30% and manifest as reduction in the width of myofibers, total protein content, RNA content, and total cytochrome c content (18, 26). In addition, models employing unloaded heterotopic heart transplants develop atrophy of about 40% within a week due to complete unloading (20, 33, 34). The mechanism of cardiac atrophy in these models has been presumed to be a reduction in cardiac work and follows the principle of symmorphosis, whereby the oxygen transport system maintains only the structural capacity necessary to match the functional demands placed upon it (27). Moreover, unloading of a single RV cardiocyte decreased the cardiocyte cross-sectional area and volume density of mitochondria and myofibrils within a week in untrained cats (54). Thus the rate of significant cardiac atrophy in sedentary humans during supine bed rest seems to be slower than in trained athletes who cease exercise training, in trained and/or untrained animals, or in heterotopic hearts.
At least one possible explanation for the differences in the rate and magnitude of atrophy in these different studies may be the relative magnitude of the reduction in cardiac work and loading conditions. Cardiac work is a function not only of wall stress (both preload and after-load) but also heart rate (chronotropic work) and contractility. Using changes in 24-h stroke work (SV × blood pressure × beats/24 h) as an estimate of overall cardiac work during bed rest, our laboratory has estimated in our previous bed rest study that normal individuals reduce their cardiac work by as much as 18% compared with freely ambulatory periods (36). This reduction may be more or less in different individuals and could be modified by countermeasures such as exercise training (40, 45).
Although there is extensive literature regarding the molecular and cellular changes associated with cardiac hypertrophy, the specific pathways involved in cardiac atrophy during decreased cardiovascular loading are less clear. It is not known whether the loss of muscle mass during bed rest and spaceflight in humans is due to changes in muscle cells (e.g., decrease in protein synthesis or even apoptosis), connective tissue, or both of these. However, microscopic studies show that the cross-sectional area of rat papillary myocytes decreases during a spaceflight for 2 wk, which is consistent with cardiac atrophy (18). Furthermore, changes in pretranslational contractile protein gene expression were detected in rat heart samples from the same space mission (53). These changes were associated with decreased growth hormone release from the anterior pituitary gland (29). Moreover, electron microscopic studies on rat cardiac cells after exposure to microgravity have shown an increase in the number of lipid droplets and the amount of glycogen, loss of microtubules, and decrease in volume density in the mitochondria in ventricular tissue (48).
Ground-based animal models of microgravity exposure, for example tail suspension in rodents, also have been used to describe the mechanism behind cardiac atrophy due to unloading (7, 23). But the results suggest that tail suspension in quadrupeds may not be optimal for examining cardiovascular adaptations to microgravity because the dominant hemodynamics are fundamentally different from those in upright humans (49). Creative approaches to translating research at the basic level to intact humans therefore must be developed before the mechanism of cardiac atrophy during bed rest or spaceflight can be determined with certainty.
Clinical Implication
There is no evidence that physiological cardiac atrophy leads to impairment of systolic function. For example, spinal cord-injured individuals who have been immobilized for many years have normal systolic volumes for a given blood pressure, suggesting normal contractile function (40). Moreover, regression of LV hypertrophy due to hypertension or valvular heart disease usually results in improved rather than impaired ventricular function (12). Finally, even after spaceflights of 8 mo, Atkov and co-workers (1, 2) found normal LV contractile function, and similar observations have been made after bed rest studies lasting more than 1 yr (56). During the 3-mo Skylab mission, M-mode echocardiography revealed that, although LV end-diastolic volume and SV were reduced immediately postflight, plots of LV end-diastolic volume vs. SV appeared to be described by virtually identical linear regression equations, suggesting no deterioration in contractile function (25). Similar preservation of preload recruitable SV despite a decrease in LV end-diastolic volume has been demonstrated after bed rest by using more modern techniques (36).However, one of the most important clinical consequences of cardiac atrophy may be for diastolic as opposed to systolic function. Invasive studies of cardiac performance before and after 2 wk of head-down-tilt bed rest have shown that there is a leftward shift in the diastolic pressure-volume curve after bed rest, resulting in a smaller LV end-diastolic volume for any given filling pressure (36, 46). Furthermore, the equilibrium volume of the left ventricle (the volume at pressure = 0 mmHg) was significantly reduced, impairing the ability to use diastolic suction to fill the left ventricle. Together, these changes result in a greatly reduced end-diastolic volume and thereby SV during orthostasis, which is seen universally after bed rest or spaceflight and may play an important role in mediating the orthostatic intolerance observed frequently after such deconditioning (36, 46). We speculate that if cardiac atrophy is more severe with longer durations of bed rest or spaceflight, as suggested by the present study, then the impairment of diastolic filling may also be worse, providing a potential explanation for the anecdotal reports that orthostatic intolerance may be more severe after long-duration vs. short-duration space missions (J. Meck, unpublished observations).
In summary, this study shows that LV (and possibly RV) atrophy occurs during prolonged supine bed rest deconditioning and may also occur after spaceflight. We suggest that this response is an appropriate "physiological" adaptation to reduced myocardial work and loading conditions.
| |
ACKNOWLEDGEMENTS |
|---|
The work herein was performed with the support of the NASA NSCORT Grant NGW3582, National Institutes of Health Grant MO1-RR-00633, and NASA contracts NAS9-16044 and NAS9-18139.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: B. D. Levine, Director, Institute for Exercise and Environmental Medicine, 7232 Greenville Ave., Suite 435, Dallas, TX 75231 (E-mail: benjaminlevine{at}texashealth.org).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 31 October 2000; accepted in final form 23 March 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Atkov, OU.
The state of cosmonauts' cardiovascular systems during long-term orbital flights.
Byulleten' Vsesoyuznogo Kardiologicheskogo Nauchnogo Tsentra AMN SSSR
8:
97-100,
1985.
2.
Atkov, O,
Bednenko VS,
and
Fomina GA.
Ultrasound techniques in space medicine.
Aviat Space Environ Med, Suppl
58:
A69-A73,
1987.
3.
Bottini, PB,
Carr AA,
Prisant LM,
Flickinger FW,
Allison JD,
and
Gottdiener JS.
Magnetic resonance imaging compared with echocardiography to assess left ventricular mass in the hypertensive patient.
Am J Hypertens
8:
221-228,
1995[Web of Science][Medline].
4.
Boxt, LM,
Katz J,
Kolb T,
Czegledy FP,
and
Barst RJ.
Direct quantification of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension.
J Am Coll Cardiol
19:
1508-1515,
1992[Abstract].
5.
Buckey, JC,
Gaffney FA,
Lane LD,
Levine BD,
Watenpaugh DE,
Wright SJ,
Yancy CW, Jr,
and
Blomqvist CG.
Central venous pressure in space.
J Appl Physiol
81:
19-25,
1996
6.
Buckey, JC, Jr,
Lane LD,
Levine BD,
Watenpaugh DE,
Wright SJ,
Moore WE,
Gaffney FA,
and
Blomqvist CG.
Orthostatic intolerance after spaceflight.
J Appl Physiol
81:
7-18,
1996
7.
Chew, HG, Jr,
and
Segal SS.
Arterial morphology and blood volumes of rats following 10-14 weeks of tail suspension.
J Mol Cell Cardiol
27:
407-417,
1995[Web of Science][Medline].
8.
Chien, KR,
Knowlton KU,
Zhu H,
and
Chien S.
Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response.
FASEB J
5:
3037-3046,
1991[Abstract].
9.
Cooper, G IV.
Load and length regulation of cardiac energetics.
Annu Rev Physiol
52:
505-522,
1990[Web of Science][Medline].
10.
Cooper, G, IV,
Kent RL,
and
Mann DL.
Load induction of cardiac hypertrophy.
J Mol Cell Cardiol, Suppl
21:
11-30,
1989.
11.
Devereux, RB,
Pini R,
Aurigemma GP,
and
Roman MJ.
Measurement of left ventricular mass: methodology and expertise.
J Hypertens
16:
257-258,
1997.
12.
Devereux, RB,
and
Roman MJ.
Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences.
Hypertens Res
22:
1-9,
1999[Web of Science][Medline].
13.
Ehsani, AA,
Hagberg JM,
and
Hickson RC.
Rapid changes in left ventricular dimensions and mass in response to physical conditioning and deconditioning.
Am J Cardiol
42:
52-56,
1978[Web of Science][Medline].
14.
Eto, Y,
Yonekura K,
Sonoda M,
Arai N,
Sata M,
Sugiura S,
Taneka K,
Gualberto A,
Hixon ML,
Wagner MW,
and
Aoyagi T.
Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training.
Circulation
101:
2134-2137,
2000
15.
Fagard, R,
Aubert A,
Lysens R,
Staessen J,
Vanhees L,
and
Amery A.
Noninvasive assessment of seasonal variations in cardiac structure and function in cyclists.
Circulation
67:
896-901,
1983
16.
Foldager, N,
Andersen TAE,
Jessen FB,
Ellegaard P,
Stadeager C,
Videbaek R,
and
Norsk P.
Central venous pressure during weightlessness in humans.
In: Scientific results of the German Spacelab-Mission D-2. Köln, Germany: DLR, 1995, p. 695-696.
17.
Fortney, SM,
Schneider VS,
and
Greenleaf JE.
The physiology of bed rest.
In: Handbook of Physiology. Environmental Physiology. Bethesda, MD: Am. Physiol. Soc, 1996, sect. 4, vol. II, p. 889-939.
18.
Frenzel, H,
Schwartzkopff B,
Höltermann W,
Schnurch HG,
Novi A,
and
Hort W.
Regression of cardiac hypertrophy: morphometric and biochemical studies in rat heart after swimming training.
J Mol Cell Cardiol
20:
737-751,
1988[Web of Science][Medline].
19.
Gaffney, FA,
Nixon JV,
Karlsson ES,
Campbell W,
Dowdey AB,
and
Blomqvist CG.
Cardiovascular deconditioning produced by 20 hours of bedrest with head-down tilt (
5°) in middle-aged healthy men.
Am J Cardiol
56:
634-638,
1985[Web of Science][Medline].
20.
Galiñanes, M,
Zhai X,
and
Hearse DJ.
The effect of load on atrophy, myosin isoform shifts and contractile function: studies in a novel rat heart transplant preparation.
J Mol Cell Cardiol
27:
407-417,
1995.
21.
Germain, P,
Roul G,
Kastler B,
Mossard JM,
Bareiss P,
and
Sacrez A.
Inter-study variability in left ventricular mass measurement: comparison between M-mode echocardiogram and MRI.
Eur Heart J
13:
1011-1019,
1992
22.
Giardina, JJ,
Malinowska K,
Pifarre R,
Hwang MH,
Robinson JA,
Loeb HS,
and
Lawless CE.
Use of cyclosporin in the mouse heterotopic heart transplant.
J Heart Transplant
9:
106-113,
1990[Web of Science][Medline].
23.
Goldstein, MA,
Edwards RJ,
and
Schroeter JP.
Cardiac morphology after conditions of microgravity during COSMOS 2044.
J Appl Physiol Suppl
73:
94S-100S,
1992.
24.
Greenleaf, JE,
Bernauer EM,
Young HL,
Morse JT,
Staley RW,
Juhos LT,
and
Van Beaumont W.
Fluid and electrolyte shifts during bed rest with isometric and isotonic exercise.
J Appl Physiol
42:
59-66,
1977
25.
Henry, WL,
Epstein SE,
Griffith JM,
Goldstein RE,
and
Redwood DR.
Effect of prolonged space flight on cardiac functions and dimensions.
In: Biomedical Results from Skylab. Greenbelt, MD: NASA, 1977, p. 366-371.
26.
Hickson, RC,
Hammons GT,
and
Holloszy JO.
Development and regression of exercise-induced cardiac hypertrophy in rats.
Am J Physiol Heart Circ Physiol
236:
H268-H272,
1979
27.
Hoppeler, H,
and
Weibel ER.
Limits for oxygen and substrate transport in mammals.
J Exp Biol
201:
1051-1064,
1998[Abstract].
28.
Hundley, WG,
Li HF,
Willard JE,
Landau C,
Lange RA,
Meshack BM,
Hillis LD,
and
Peshock RM.
Magnetic resonance imaging assessment of the severity of mitral regurgitation: a comparison with invasive techniques.
Circulation
92:
1151-1158,
1995
29.
Hymer, WC,
Grindeland R,
Krasnov I,
Victorov I,
Motter K,
Mukherjee P,
Shellenberger K,
and
Vasques M.
Effects of spaceflight on rat pituitary cell function.
J Appl Physiol
73:
151S-157S,
1992.
30.
Katz, AM.
Cardiomyopathy of overload.
N Engl J Med
322:
100-110,
1990[Web of Science][Medline].
31.
Katz, J,
Milliken MC,
Stray-Gundersen J,
Buja LM,
Parkey RW,
Mitchell JH,
and
Peshock RM.
Estimation of human myocardial mass with MRI imaging.
Radiology
169:
495-498,
1988
32.
Kent, RL,
Mann DL,
and
Cooper GIV
Signals for cardiac muscle hypertrophy in hypertension.
J Cardiovasc Pharmacol
17:
S7-S13,
1991.
33.
Kolár, F,
MacNaughton C,
Papousek F,
and
Korecky B.
Systolic mechanical performance of heterotopically transplanted hearts in rats treated with cyclosporin.
Cardiovasc Res
27:
1244-1247,
1993[Web of Science][Medline].
34.
Korecky, B,
and
Masika M.
Direct effect of increased hemodynamic load on cardiac mass.
Circ Res
68:
1174-1178,
1991
35.
Leach, CS,
Alfrey CP,
Suki WA,
Leonard JI,
Rambaut PC,
Inners LD,
Smith SM,
Lane HW,
and
Krauhs JM.
Regulation of body fluid compartments during short-term spaceflight.
J Appl Physiol
81:
105-116,
1996
36.
Levine, BD,
Zuckerman JH,
and
Pawelczyk JA.
Cardiac atrophy after bed-rest deconditioning. A nonneural mechanism for orthostatic intolerance.
Circulation
96:
517-525,
1997
37.
Levine, BD,
Zuckerman JH,
Zhang R,
Franco F,
Perhonen M,
and
Peshock RM.
Adaptive range of human physiological hypertrophy/atrophy (Abstract).
Circulation
100:
I140,
1999.
38.
Maron, BJ,
Pelliccia A,
Spataro A,
and
Granata M.
Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes.
Br Heart J
69:
125-128,
1993
39.
Milliken, M,
Stray-Gundersen J,
Peshock RM,
Katz J,
and
Mitchell J.
Left ventricular mass as determined by magnetic resonance imaging in male endurance athletes.
Am J Cardiol
62:
301-305,
1988[Web of Science][Medline].
40.
Nash, MS,
Bilsker S,
Marcillo AE,
Issac SM,
Botelho LA,
Klose KJ,
Green BA,
and
Rountree MT.
Reversal of adaptive left ventricular atrophy following electrically-stimulated exercise training in human tetraplegics.
Paraplegia
29:
590-599,
1991[Web of Science][Medline].
41.
Nixon, JV,
Gordon Murray R,
Bryant C,
Johnson RL,
Mitchell JH,
Holland OB,
Gomez-Sanches C,
Vergne-Marini P,
and
Blomqvist CG.
Early cardiovascular adaptation to simulated zero gravity.
J Appl Physiol
46:
541-548,
1979
42.
Norsk, P,
Drummer C,
Rocker L,
Strollo F,
Christensen NJ,
Warberg J,
Bie P,
Stadeager C,
Johansen LB,
Heer M,
Gunga H-C,
and
Gerzer R.
Renal and endocrine responses in humans to isotonic saline infusion during microgravity.
J Appl Physiol
78:
2253-2259,
1995
43.
Pattynama, PMT,
Lamb HJ,
Van der Velde EA,
Van der Geest RJ,
Van der Wall EE,
and
De Roos A.
Reproducibility of MRI-derived measurements of right ventricular volumes and myocardial mass.
Magn Reson Imaging
13:
53-64,
1995[Web of Science][Medline].
44.
Pawelczyk, JA,
Levine BD,
Prisk GK,
Shykoff BE,
Elliot AR,
and
Rosow E.
Accuracy and precision of flight systems for determination of cardiac output by soluble gas rebreathing.
In: Proc NASA/AIAA Life Sci Space Med Conf 12th Houston, TX, 1995, p. LS95-LS130.
45.
Perhonen, MA,
Zuckerman JH,
Hinojosa JR,
Zhang R,
Iwasaki K,
and
Levine BD.
Exercise training reverses cardiac atrophy during head-down tilt bed rest (Abstract).
Med Sci Sports Exerc
93:
S53,
2000.
46.
Perhonen, MA,
Zuckerman JH,
and
Levine BD.
Deterioration of left ventricular camber performance after bed rest: "cardiovascular deconditioning" or hypovolemia?
Circulation
103:
1851-1857,
2001
47.
Peshock, RM,
Willett DL,
Sayad DE,
Hundley WG,
Chialkowski MC,
Clarke GD,
and
Parkey RW.
Quantitative MR imaging of the heart.
MRI Clinics
4:
287-305,
1996.
48.
Philpott, DE,
Popova IA,
Kato K,
Stevenson J,
Miquel J,
and
Sapp W.
Morphological and biochemical examination of Cosmos 1887 rat heart tissue. Part I. Ultrastructure.
FASEB J
4:
73-78,
1990[Abstract].
49.
Rowell, LB.
Human Cardiovascular Control. New York, NY: Oxford University Press, 1993.
50.
Saltin, B,
Blomqvist G,
Mitchell JH,
Johnson RL, Jr,
Widenthal K,
and
Chapman CB.
Response to exercise after bed rest and after training. A longitudinal study of adaptive changes in oxygen transport and body composition.
Circulation, Suppl
38:
VII-1-VII-78,
1968.
51.
Shapiro, LM,
and
Smith RG.
Effect of training on left ventricular structure and function. An echocardiographic study.
Br Heart J
50:
534-539,
1983
52.
Sussman, MA,
Lim HW,
Gude N,
Taigen T,
Olson EN,
Robbins J,
Colbert MC,
Gualberto A,
Wieczorek DF,
and
Molkentin JD.
Prevention of cardiac hypertrophy in mice by calcineurin inhibition.
Science
281:
1690-1693,
1998
53.
Thomason, DB,
Morrison PR,
Oganov V,
Ilyina-Kakueva E,
Booth FW,
and
Baldwin KM.
Altered actin and myosin expression in muscle during exposure to microgravity.
J Appl Physiol, Suppl
73:
90S-93S,
1992.
54.
Thompson, EW,
Marino TA,
Uboh CE,
Kent RL,
and
Cooper GIV
Atrophy reversal and cardiocyte redifferentiation in reloaded cat myocardium.
Circ Res
54:
367-377,
1984
55.
Triebwasser, JH,
Johnson RL,
Burpo RP,
Campbell JC,
Reardon WC,
and
Blomqvist CG.
Noninvasive determination of cardiac output by a modified acetylene rebreathing procedure utilizing mass spectrometer measurements.
Aviat Space Environ Med
48:
203-209,
1977[Medline].
56.
Turbasoc, VD,
Artamonova NP,
Golubchikova ZA,
Saikina GP,
Nechaeva EI,
and
Antonenko LV.
[Cardiac bioelectrical activity in healthy men during 370-day head-down tilt hypokinesia].
Aviakosm Ekolog Med
26:
39-41,
1992.
57.
Videbaek, R,
and
Norsk P.
Arterial distension in humans during microgravity induced by parabolic flights.
J Appl Physiol
83:
1862-1866,
1997
58.
Verbanck, S,
Larsson H,
Linnarsson D,
Prisk GK,
West JB,
and
Paiva M.
Pulmonary tissue volume, cardiac output, and diffusing capacity in sustained microgravity.
J Appl Physiol
83:
810-816,
1997
59.
White, RJ,
and
Blomqvist CG.
Central venous pressure and cardiac function during spaceflight.
J Appl Physiol
85:
738-746,
1988
60.
Zerwekh, JE,
Ruml LA,
Gottschalk F,
and
Pak CYC
The effect of twelve weeks of bed rest on bone histology, biochemical marker of bone turnover, and calcium homeostasis in eleven normal subjects.
J Bone Miner Res
13:
1594-1601,
1998[Web of Science][Medline].
61.
Zile, MR,
Tomita M,
Ishihara K,
Nakano K,
Lindroth J,
Spinale F,
Swindle M,
and
Carabello BA.
Changes in diastolic function during development and correction of chronic LV volume overload produced by mitral regurgitation.
Circulation
87:
1378-1388,
1993
62.
Zimmer, HG,
Irlbeck M,
and
Kolbeck-Rühmkorff C.
Response of the rat heart to catecholamines and thyroid hormones.
Mol Cell Biochem
147:
105-114,
1995[Web of Science][Medline].
This article has been cited by other articles:
![]() |
L.-F. Zhang, J.-H. Cheng, X. Liu, S. Wang, Y. Liu, H.-B. Lu, and J. Ma Cardiovascular changes of conscious rats after simulated microgravity with and without daily -Gx gravitation J Appl Physiol, October 1, 2008; 105(4): 1134 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Dorfman, B. D. Rosen, M. A. Perhonen, T. Tillery, R. McColl, R. M. Peshock, and B. D. Levine Diastolic suction is impaired by bed rest: MRI tagging studies of diastolic untwisting J Appl Physiol, April 1, 2008; 104(4): 1037 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hill and E. N. Olson Cardiac Plasticity N. Engl. J. Med., March 27, 2008; 358(13): 1370 - 1380. [Full Text] [PDF] |
||||
![]() |
S. Masuki, J. H. Eisenach, W. G. Schrage, C. P. Johnson, N. M. Dietz, B. W. Wilkins, P. Sandroni, P. A. Low, and M. J. Joyner Reduced stroke volume during exercise in postural tachycardia syndrome J Appl Physiol, October 1, 2007; 103(4): 1128 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Dorfman, B. D. Levine, T. Tillery, R. M. Peshock, J. L. Hastings, S. M. Schneider, B. R. Macias, G. Biolo, and A. R. Hargens Cardiac atrophy in women following bed rest J Appl Physiol, July 1, 2007; 103(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Baevsky, V. M. Baranov, I. I. Funtova, A. Diedrich, A. V. Pashenko, A. G. Chernikova, J. Drescher, J. Jordan, and J. Tank Autonomic cardiovascular and respiratory control during prolonged spaceflights aboard the International Space Station J Appl Physiol, July 1, 2007; 103(1): 156 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masuki, J. H. Eisenach, C. P. Johnson, N. M. Dietz, L. M. Benrud-Larson, W. G. Schrage, T. B. Curry, P. Sandroni, P. A. Low, and M. J. Joyner Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety J Appl Physiol, March 1, 2007; 102(3): 896 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Mueller, M. J. Sullivan, R. R. Grindstaff, J. T. Cunningham, and E. M. Hasser Regulation of plasma vasopressin and renin activity in conscious hindlimb-unloaded rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R46 - R52. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Iellamo, M. Di Rienzo, D. Lucini, J. M. Legramante, P. Pizzinelli, P. Castiglioni, F. Pigozzi, M. Pagani, and G. Parati Muscle metaboreflex contribution to cardiovascular regulation during dynamic exercise in microgravity: insights from mission STS-107 of the space shuttle Columbia J. Physiol., May 1, 2006; 572(3): 829 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Pancheva, V. S. Panchev, A. V. Suvandjieva, and B. D. Levine Lower body negative pressure vs. lower body positive pressure to prevent cardiac atrophy after bed rest and spaceflight. What caused the controversy? J Appl Physiol, March 1, 2006; 100(3): 1090 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Norsk, M. Damgaard, L. Petersen, M. Gybel, B. Pump, A. Gabrielsen, and N. J. Christensen Vasorelaxation in Space Hypertension, January 1, 2006; 47(1): 69 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hayashi, S. Koba, and T. Yoshida Disuse atrophy increases the muscle mechanoreflex in rats J Appl Physiol, October 1, 2005; 99(4): 1442 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Christensen, M. Heer, K. Ivanova, and P. Norsk Sympathetic nervous activity decreases during head-down bed rest but not during microgravity J Appl Physiol, October 1, 2005; 99(4): 1552 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Mueller, C. M. Foley, and E. M. Hasser Hindlimb unloading alters nitric oxide and autonomic control of resting arterial pressure in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R140 - R147. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gisolf, R. V. Immink, J. J. van Lieshout, W. J. Stok, and J. M. Karemaker Orthostatic blood pressure control before and after spaceflight, determined by time-domain baroreflex method J Appl Physiol, May 1, 2005; 98(5): 1682 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H Naylor, L. F Arnolda, J. A Deague, D. Playford, A. Maurogiovanni, G. O'Driscoll, and D. J Green Reduced ventricular flow propagation velocity in elite athletes is augmented with the resumption of exercise training J. Physiol., March 15, 2005; 563(3): 957 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Barbato, Q.-Q. Huang, M. M. Hossain, M. Bond, and J.-P. Jin Proteolytic N-terminal Truncation of Cardiac Troponin I Enhances Ventricular Diastolic Function J. Biol. Chem., February 25, 2005; 280(8): 6602 - 6609. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Spaak, S. Montmerle, P. Sundblad, and D. Linnarsson Long-term bed rest-induced reductions in stroke volume during rest and exercise: cardiac dysfunction vs. volume depletion J Appl Physiol, February 1, 2005; 98(2): 648 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Grenon, S. Hurwitz, N. Sheynberg, X. Xiao, B. Judson, C. D. Ramsdell, C. Kim, R. J. Cohen, and G. H. Williams Sleep restriction does not affect orthostatic tolerance in the simulated microgravity environment J Appl Physiol, November 1, 2004; 97(5): 1660 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arbab-Zadeh, E. Dijk, A. Prasad, Q. Fu, P. Torres, R. Zhang, J. D. Thomas, D. Palmer, and B. D. Levine Effect of Aging and Physical Activity on Left Ventricular Compliance Circulation, September 28, 2004; 110(13): 1799 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Graebe, E. L. Schuck, P. Lensing, L. Putcha, and H. Derendorf Physiological, Pharmacokinetic, and Pharmacodynamic Changes in Space J. Clin. Pharmacol., August 1, 2004; 44(8): 837 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Grenon, S. Hurwitz, N. Sheynberg, X. Xiao, C. D. Ramsdell, C. L. Mai, C. Kim, R. J. Cohen, and G. H. Williams Role of individual predisposition in orthostatic intolerance before and after simulated microgravity J Appl Physiol, May 1, 2004; 96(5): 1714 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xiao, R. Mukkamala, N. Sheynberg, S. M. Grenon, M. D. Ehrman, T. J. Mullen, C. D. Ramsdell, G. H. Williams, and R. J. Cohen Effects of simulated microgravity on closed-loop cardiovascular regulation and orthostatic intolerance: analysis by means of system identification J Appl Physiol, February 1, 2004; 96(2): 489 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fu, A. Arbab-Zadeh, M. A. Perhonen, R. Zhang, J. H. Zuckerman, and B. D. Levine Hemodynamics of orthostatic intolerance: implications for gender differences Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H449 - H457. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Adams, V. J. Caiozzo, and K. M. Baldwin Skeletal muscle unweighting: spaceflight and ground-based models J Appl Physiol, December 1, 2003; 95(6): 2185 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Watenpaugh and B. Levine Nocturnal lower body positive pressure to counteract microgravity-induced cardiac remodeling/atrophy J Appl Physiol, May 1, 2002; 92(5): 2222 - 2223. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |